-
1
-
-
0031931426
-
Classification and epidemiology of scleroderma
-
Mayes MD. Classification and epidemiology of scleroderma. Semin Cutan Med Surg 1998;17:22-6.
-
(1998)
Semin Cutan Med Surg
, vol.17
, pp. 22-26
-
-
Mayes, M.D.1
-
2
-
-
85016933431
-
Systemic sclerosis-scleroderma
-
Haustein UF. Systemic sclerosis-scleroderma. Dermatol Online J 2002;81:3.
-
(2002)
Dermatol Online J
, vol.81
, pp. 3
-
-
Haustein, U.F.1
-
3
-
-
0033753187
-
Vascular function in systemic sclerosis
-
Herric AL. Vascular function in systemic sclerosis. Curr Opin Rheumatol 2000;12:527.
-
(2000)
Curr Opin Rheumatol
, vol.12
, pp. 527
-
-
Herric, A.L.1
-
4
-
-
0028026729
-
Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis
-
Herric AL, Rieley F, Schofield D. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 1994;21:1477-83.
-
(1994)
J Rheumatol
, vol.21
, pp. 1477-1483
-
-
Herric, A.L.1
Rieley, F.2
Schofield, D.3
-
5
-
-
33846174285
-
The oxidant antioxidant balance in systemic sclerosis cases with interstitial lung involvement
-
Musellim B, Iktimur H, Uzun H, Ongen G. The oxidant antioxidant balance in systemic sclerosis cases with interstitial lung involvement. Rheumatol Int 2006;27:163-7.
-
(2006)
Rheumatol Int
, vol.27
, pp. 163-167
-
-
Musellim, B.1
Iktimur, H.2
Uzun, H.3
Ongen, G.4
-
6
-
-
68149180846
-
Antioxidant effect of iloprost: Current knowledge and therapeutic implications for systemic sclerosis
-
Erre GL, Passiu G. Antioxidant effect of iloprost: Current knowledge and therapeutic implications for systemic sclerosis. Rheumatismo 2009;61:90-7.
-
(2009)
Rheumatismo
, vol.61
, pp. 90-97
-
-
Erre, G.L.1
Passiu, G.2
-
7
-
-
0029915092
-
Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis
-
Herric AL, Worthington H, Rieley F. Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis. J Rheumatol 1996;23:650-3.
-
(1996)
J Rheumatol
, vol.23
, pp. 650-653
-
-
Herric, A.L.1
Worthington, H.2
Rieley, F.3
-
8
-
-
0021719010
-
Essential fatty metabolism in diseases of connective tissue with special reference to scleroderma and sjogren's syndrome
-
Horrobin DF. Essential fatty metabolism in diseases of connective tissue with special reference to scleroderma and sjogren's syndrome. Med Hypotheses 1984;14:233-47.
-
(1984)
Med Hypotheses
, vol.14
, pp. 233-247
-
-
Horrobin, D.F.1
-
9
-
-
0031792985
-
Microchimerism and the pathogenesis of systemic sclerosis
-
Nelson JL. Microchimerism and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 1998;10:564-71.
-
(1998)
Curr Opin Rheumatol
, vol.10
, pp. 564-571
-
-
Nelson, J.L.1
-
10
-
-
0043074631
-
Prevalance, incidence, survival and disease characteristics of systemic sclerosis in a large US population
-
Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalance, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2246-2255
-
-
Mayes, M.D.1
Lacey Jr., J.V.2
Beebe-Dimmer, J.3
Gillespie, B.W.4
Cooper, B.5
Laing, T.J.6
|